So, IGF-1, leptin, and adiponectin are considered non-invasive biomarkers for non-alcoholic fatty liver diseases (NAFLD) diagnosis [10]. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.